Search result for United States Food and Drug Administration
Cipla drops 5 percent as a result of fears against Goa unit
The Indian multinational biotechnology and pharmaceutical company-Cipla has dropped to 5% in Friday’s session. The dive is attributed to extensive changes by Capital market company-Equirius, which said the unit will have to meet the changes as per the USFDA guidelines.
News sou...